Paper Details
- Home
- Paper Details
Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States.
Author: BernsteinDavid, DieterichDouglas T, FlammSteven, PockrosPaul J, ReauNancy
Original Abstract of the Article :
Label="BACKGROUND">Thrombocytopenia is the most common haematological abnormality in patients with chronic liver disease in the United States. Severe thrombocytopenia (platelet count <50 × 10<sup>9</sup> /L) can complicate the management of patients with chronic liver disease by significantl...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/apt.16044
データ提供:米国国立医学図書館(NLM)
A Treatment Algorithm for Chronic Liver Disease and Severe Thrombocytopenia: Navigating the Shifting Sands
This review article dives into the complex world of managing patients with chronic liver disease and severe thrombocytopenia, a challenging situation that requires careful navigation and thoughtful decision-making. The authors present a comprehensive treatment algorithm, providing a roadmap for clinicians to effectively manage the risks of bleeding during elective medical procedures. This research is like charting a course through a vast and intricate desert, seeking to provide clear guidance for navigating a complex medical situation.
Novel Agents Offer Alternatives to Platelet Transfusions
The review highlights the emergence of novel agents, such as avatrombopag and lusutrombopag, as potential alternatives to platelet transfusion for managing severe thrombocytopenia in patients with chronic liver disease. These promising agents target the thrombopoietin pathway, offering a new avenue for addressing this challenging hematological complication. It's like discovering a new oasis in the desert, providing a source of sustenance and support for those seeking a more effective approach to managing thrombocytopenia.
Improving Outcomes for Patients with Chronic Liver Disease
The authors emphasize the importance of individualized treatment approaches, tailoring care to the specific needs of each patient with chronic liver disease and severe thrombocytopenia. By understanding the underlying factors contributing to thrombocytopenia and considering the risks and benefits of different treatment options, clinicians can develop personalized strategies to improve patient outcomes. It's like navigating a desert landscape, recognizing the unique challenges and opportunities presented by each terrain.
Dr. Camel's Conclusion
This comprehensive review provides a valuable framework for managing patients with chronic liver disease and severe thrombocytopenia. The authors offer a clear and practical treatment algorithm, highlighting the importance of individualized care and exploring novel therapeutic approaches. Just as a camel adapts to the ever-changing conditions of the desert, we must continue to adapt our approach to managing chronic liver disease, seeking innovative solutions that improve the lives of those affected by this challenging condition.
Date :
- Date Completed 2021-01-19
- Date Revised 2021-01-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.